This page uses javascripts, but your browser is not currently supporting JavaScripts. Please turn ON scripting in your web browser. Skip to Content

Buprenorphine
Home What is Buprenorphine? Buprenorphine Products DATA Physician Locator DATA 2000 FAQs Links En Español Physician Waiver Qualifications Waiver Notification Form Ongoing Web-based Trainings Waived Physician WebBoard Update Physician Contact Information Model State Medical Board Policy
Buprenorphine Summits Articles SAMHSA Reports Other Gov't Reports To check on a physician's waivered status, please call the Buprenorphine Information Center at 1.866.287.2728. Nurses Guide to Buprenorphine Online Buprenorphine Course for Counselors

 
Buprenorphine Summit Presentations

The Summit convened February 21-22, 2008, in Washington, D.C., brought together experts in epidemiology, pharmacology, toxicology, and addiction treatment in order to build upon the findings of the previous summits in 2003 and 2005. Participants assessed the successes, progress, and continued barriers to access to opioid treatment with buprenorphine. Presentations identified best practices and useful clinical supports to enhance the quality of treatment. Participants identified strategies to address emerging issues and concerns.

 


Go to U.S. Department of Health and Human Services
Home | Accessibility | Privacy | Disclaimer | SAMHSA
Department of Health & Human Services | USA.gov

* Adobe™ PDF formatted files require the Adobe™ Reader to properly read them. Use this link to download this FREE program.

Go to Division of Pharmacologic Therapies